It has been shown that up to 85% of subjects with NAFLD compared to 30% in controls are insulin resistant and have abnormal glucose metabolism, i.e., prediabetes or T2DM, of which they were unaware [68]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.